Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal

Anna Lasorella, Renata Boldrini, Carlo Dominici, Alberto Donfrancesco, Yoshifumi Yokota, Alessandro Inserra, Antonio Iavarone

Research output: Contribution to journalArticle

Abstract

Perturbation of the function of the retinoblastoma (Rb) protein is found in most human tumors. Id2 is a natural target of the Rb protein that is recruited by Myc oncoproteins to bypass the tumor suppressor function of Rb. Here we report that an "N-Myc-Id2 pathway" persists during late development of the nervous system and parallels the rising levels of active Rb in neuronal precursors withdrawing from the cell cycle. An immunohistochemical analysis of primary neuroblastoma from 47 patients shows that expression of Id2 is strongly predictive of poor outcome, irrespective of other clinical and biological variables. Overexpression of Id2 mediates cellular transformation and is required to maintain the malignant behavior of neuroblastoma cells. Correspondingly, embryonic fibroblasts from Id2-null mice display impaired ability to proliferate. We suggest that Id2 overexpression may be a better prognostic indicator than N-myc gene amplification in neuroblastoma. Thus, disrupting Id2 function may lead to new and useful therapeutic strategies for cancer patients.

Original languageEnglish
Pages (from-to)301-306
Number of pages6
JournalCancer Research
Volume62
Issue number1
Publication statusPublished - Jan 1 2002

Fingerprint

Neuroblastoma
Retinoblastoma Protein
Retinoblastoma
Cell Proliferation
Neoplasms
myc Genes
Aptitude
Gene Amplification
Oncogene Proteins
Nervous System
Cell Cycle
Fibroblasts
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lasorella, A., Boldrini, R., Dominici, C., Donfrancesco, A., Yokota, Y., Inserra, A., & Iavarone, A. (2002). Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal. Cancer Research, 62(1), 301-306.

Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal. / Lasorella, Anna; Boldrini, Renata; Dominici, Carlo; Donfrancesco, Alberto; Yokota, Yoshifumi; Inserra, Alessandro; Iavarone, Antonio.

In: Cancer Research, Vol. 62, No. 1, 01.01.2002, p. 301-306.

Research output: Contribution to journalArticle

Lasorella, A, Boldrini, R, Dominici, C, Donfrancesco, A, Yokota, Y, Inserra, A & Iavarone, A 2002, 'Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal', Cancer Research, vol. 62, no. 1, pp. 301-306.
Lasorella, Anna ; Boldrini, Renata ; Dominici, Carlo ; Donfrancesco, Alberto ; Yokota, Yoshifumi ; Inserra, Alessandro ; Iavarone, Antonio. / Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal. In: Cancer Research. 2002 ; Vol. 62, No. 1. pp. 301-306.
@article{85f331473ec14cce81610d05e50dd7c8,
title = "Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal",
abstract = "Perturbation of the function of the retinoblastoma (Rb) protein is found in most human tumors. Id2 is a natural target of the Rb protein that is recruited by Myc oncoproteins to bypass the tumor suppressor function of Rb. Here we report that an {"}N-Myc-Id2 pathway{"} persists during late development of the nervous system and parallels the rising levels of active Rb in neuronal precursors withdrawing from the cell cycle. An immunohistochemical analysis of primary neuroblastoma from 47 patients shows that expression of Id2 is strongly predictive of poor outcome, irrespective of other clinical and biological variables. Overexpression of Id2 mediates cellular transformation and is required to maintain the malignant behavior of neuroblastoma cells. Correspondingly, embryonic fibroblasts from Id2-null mice display impaired ability to proliferate. We suggest that Id2 overexpression may be a better prognostic indicator than N-myc gene amplification in neuroblastoma. Thus, disrupting Id2 function may lead to new and useful therapeutic strategies for cancer patients.",
author = "Anna Lasorella and Renata Boldrini and Carlo Dominici and Alberto Donfrancesco and Yoshifumi Yokota and Alessandro Inserra and Antonio Iavarone",
year = "2002",
month = "1",
day = "1",
language = "English",
volume = "62",
pages = "301--306",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Id2 is critical for cellular proliferation and is the oncogenic effector of N-Myc in human neuroblastomal

AU - Lasorella, Anna

AU - Boldrini, Renata

AU - Dominici, Carlo

AU - Donfrancesco, Alberto

AU - Yokota, Yoshifumi

AU - Inserra, Alessandro

AU - Iavarone, Antonio

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Perturbation of the function of the retinoblastoma (Rb) protein is found in most human tumors. Id2 is a natural target of the Rb protein that is recruited by Myc oncoproteins to bypass the tumor suppressor function of Rb. Here we report that an "N-Myc-Id2 pathway" persists during late development of the nervous system and parallels the rising levels of active Rb in neuronal precursors withdrawing from the cell cycle. An immunohistochemical analysis of primary neuroblastoma from 47 patients shows that expression of Id2 is strongly predictive of poor outcome, irrespective of other clinical and biological variables. Overexpression of Id2 mediates cellular transformation and is required to maintain the malignant behavior of neuroblastoma cells. Correspondingly, embryonic fibroblasts from Id2-null mice display impaired ability to proliferate. We suggest that Id2 overexpression may be a better prognostic indicator than N-myc gene amplification in neuroblastoma. Thus, disrupting Id2 function may lead to new and useful therapeutic strategies for cancer patients.

AB - Perturbation of the function of the retinoblastoma (Rb) protein is found in most human tumors. Id2 is a natural target of the Rb protein that is recruited by Myc oncoproteins to bypass the tumor suppressor function of Rb. Here we report that an "N-Myc-Id2 pathway" persists during late development of the nervous system and parallels the rising levels of active Rb in neuronal precursors withdrawing from the cell cycle. An immunohistochemical analysis of primary neuroblastoma from 47 patients shows that expression of Id2 is strongly predictive of poor outcome, irrespective of other clinical and biological variables. Overexpression of Id2 mediates cellular transformation and is required to maintain the malignant behavior of neuroblastoma cells. Correspondingly, embryonic fibroblasts from Id2-null mice display impaired ability to proliferate. We suggest that Id2 overexpression may be a better prognostic indicator than N-myc gene amplification in neuroblastoma. Thus, disrupting Id2 function may lead to new and useful therapeutic strategies for cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=0036144570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036144570&partnerID=8YFLogxK

M3 - Article

C2 - 11782392

AN - SCOPUS:0036144570

VL - 62

SP - 301

EP - 306

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 1

ER -